Patent details
EP2291189 Title: METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME
Basic Information
- Publication number:
- EP2291189
- PCT Application Number:
- PCT/US/2009/044156
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP097512495
- PCT Publication Number:
- WO/2009/143020
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME
- French Title of Invention:
- PROCÉDÉ DE TRAITEMENT DE L'HYPERURICÉMIE À L'AIDE D'UN INHIBITEUR DE SGLT2 ET COMPOSITION LE CONTENANT
- German Title of Invention:
- VERFAHREN ZUR BEHANDLUNG VON HYPERURIKÄMIE MIT EINEM SGLT2-INHIBITOR UND DIESEN ENTHALTENDE ZUSAMMENSETZUNG
- SPC Number:
Dates
- Filing date:
- 15/05/2009
- Grant date:
- 01/10/2014
- EP Publication Date:
- 01/10/2014
- PCT Publication Date:
- 26/11/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/03/2011
- EP B1 Publication Date:
- 01/10/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/05/2015
- Expiration date:
- 15/05/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 15/05/2009
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Inventor
- Name:
- LESLIE Bruce, Robert
- Address:
- United States (US)
Priority
- Priority Number:
- 55352 P
- Priority Date:
- 22/05/2008
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/7004;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|